BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23499499)

  • 1. The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysis.
    Molica S; Giannarelli D; Gentile M; Cutrona G; Di Renzo N; Di Raimondo F; Neri A; Federico M; Ferrarini M; Morabito F
    Leuk Res; 2013 Aug; 37(8):943-7. PubMed ID: 23499499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemia.
    Molica S; Giannarelli D; Gentile M; Cutrona G; Di Renzo N; Di Raimondo F; Neri A; Federico M; Ferrrarini M; Morabito F
    Cancer; 2013 Mar; 119(6):1177-85. PubMed ID: 23224939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model.
    Molica S; Giannarelli D; Mirabelli R; Levato L; Russo A; Linardi M; Gentile M; Morabito F
    Eur J Haematol; 2016 Jan; 96(1):72-7. PubMed ID: 25819739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
    Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
    Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia.
    Bulian P; Tarnani M; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; Deaglio S; D'Arena G; Efremov D; Marasca R; Lauria F; Gattei V; Gaidano G; Laurenti L
    Hematol Oncol; 2011 Jun; 29(2):91-9. PubMed ID: 20669154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative assessment of prognostic models in chronic lymphocytic leukemia: evaluation in Indian cohort.
    Rani L; Gogia A; Singh V; Kumar L; Sharma A; Kaur G; Gupta R
    Ann Hematol; 2019 Feb; 98(2):437-443. PubMed ID: 30338367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index.
    Muñoz-Novas C; Poza-Santaella M; González-Gascón Y Marín I; Hernández-Sánchez M; Rodríguez-Vicente AE; Infante MS; Heras C; Foncillas MÁ; Marín K; Hernández-Rivas JM; Hernández JÁ
    Biomed Res Int; 2018; 2018():9506979. PubMed ID: 29736400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.
    Molica S; Shanafelt TD; Giannarelli D; Gentile M; Mirabelli R; Cutrona G; Levato L; Di Renzo N; Di Raimondo F; Musolino C; Angrilli F; Famà A; Recchia AG; Chaffee KG; Neri A; Kay NE; Ferrarini M; Morabito F
    Am J Hematol; 2016 Nov; 91(11):1090-1095. PubMed ID: 27465919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the prognosis of early stage chronic lymphocytic leukaemia patients.
    Pepper C; Majid A; Lin TT; Hewamana S; Pratt G; Walewska R; Gesk S; Siebert R; Wagner S; Kennedy B; Miall F; Davis ZA; Tracy I; Gardiner AC; Brennan P; Hills RK; Dyer MJ; Oscier D; Fegan C
    Br J Haematol; 2012 Feb; 156(4):499-507. PubMed ID: 22171799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of early chronic lymphocytic leukemia. A single institution study with emphasis on the impact of disease-progression on overall survival.
    Molica S; Levato D; Dattilo A
    Haematologica; 1999 Dec; 84(12):1094-9. PubMed ID: 10586211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.
    Gao R; Man TS; Liang JH; Wang L; Zhu HY; Wu W; Fan L; Li JY; Yang T; Xu W
    Cancer Res Treat; 2020 Jan; 52(1):189-206. PubMed ID: 31291713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases.
    Gentile M; Mauro FR; Rossi D; Vincelli I; Tripepi G; Recchia AG; De Stefano L; Campanelli M; Giannarelli D; Bossio S; Morabito L; Vigna E; Gaidano G; Foà R; Morabito F
    Br J Haematol; 2014 Oct; 167(2):224-32. PubMed ID: 25041609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factor analysis in 203 patients with chronic lymphocytic leukaemia].
    Wu T; Li ZJ; Wang YF; Zhao YZ; Qi JY; Qian LS; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jul; 30(7):435-9. PubMed ID: 19954591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia.
    Gao R; Chen RZ; Xia Y; Liang JH; Wang L; Zhu HY; Zhu Wu J; Fan L; Li JY; Yang T; Xu W
    Int J Cancer; 2018 Aug; 143(3):466-477. PubMed ID: 29457831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
    Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
    Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: external validation in a phase III trial comparing vinflunine with docetaxel.
    Di Maio M; Krzakowski M; Fougeray R; Kowalski DM; Gridelli C
    Lung Cancer; 2012 Jul; 77(1):116-20. PubMed ID: 22361218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.
    Zucchetto A; Bomben R; Dal Bo M; Sonego P; Nanni P; Rupolo M; Bulian P; Dal Maso L; Del Poeta G; Del Principe MI; Degan M; Gattei V
    J Cell Physiol; 2006 May; 207(2):354-63. PubMed ID: 16331666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.